Difference between revisions of "Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking"

From Murray Wiki
Jump to navigationJump to search
(Created page with "{{Paper |Title=Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking |Authors=Sam...")
 
 
Line 8: Line 8:
 
|ID=2019g
 
|ID=2019g
 
|Tag=CM19-biorxiv
 
|Tag=CM19-biorxiv
|Funding=ICB Network19
 
 
|Flags=Biocircuits
 
|Flags=Biocircuits
 
}}
 
}}

Latest revision as of 14:33, 12 September 2021

Title Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking
Authors Samuel Clamons, Richard Murray
Source bioRxiv preprint
Abstract Synthetic transcriptional networks built from CRISPR-based repressors (CRISPRi) rely on shared use of a core dCas9 protein. In E. coli, CRISPRi cannot support more than about a dozen simultaneous gRNAs before the fold repression of any individual gRNA drops below 10x. We show with a simple model based on previous characterization of competition in CRISPRi that activation by CRISPR-based activators (CRISPRa) is much less sensitive to dCas9 bottle-necking than CRISPRi. We predict that E. coli should be able to support dozens to hundreds of CRISPRa gRNAs at >10-fold activation.
Type Preprint
URL https://www.biorxiv.org/content/10.1101/719278v2
Tag CM19-biorxiv
ID 2019g
Funding
Flags Biocircuits